Feminizing Treatment in Transgender Women and Non-binary Persons
ConditionTransgenderism
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age18+
SponsorOdense University Hospital
About this trial
Cohort study in 100 transgender women treated with gender affirming hormone treatment. Follow up affter 1year, 3 years, 5 years and 10 years, Outcomes regarding cardiovascular effects of hormone treatment.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
assigned male at birth and eligeble for gender affirming feminizing treatment
Disqualifiers
None
Trial population
transgender women
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
standard treatment
Other interventionstarndard treatment for transgender women
Treatment groups
100 Participants
are divided into 1 treatment groupGroup A: transgender women1 intervention
Trial outcomes
Primary outcomes
1
coronary plaque formation
mm3
Time frame
1 yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov